Advanced in Age-Related Macular Degeneration (ARMD)

Dr. Rosa Y. Kim

Ophthalmology
Retina Consultants Of Houston PLLC
10907 Memorial Hermann Dr, Suite 450, 
Pearland, TX 
Accepting New Patients

Advanced in Age-Related Macular Degeneration (ARMD)
Retina Consultants Of Houston PLLC
10907 Memorial Hermann Dr, Suite 450, 
Pearland, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rosa Kim is an Ophthalmologist in Pearland, Texas. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Uveitis, Punctate Inner Choroidopathy, Neuroretinitis, Late-Onset Retinal Degeneration, and Vitrectomy. Dr. Kim is currently accepting new patients.

Her clinical research consists of co-authoring 8 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles and participated in 2 clinical trials in the study of Age-Related Macular Degeneration (ARMD).

Specialties
Ophthalmology
Licenses
Ophthalmology in TX
Hospital Affiliations
Houston Methodist Hospital
Languages Spoken
English
Korean
Spanish
Vietnamese
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Chinese Community Health
  • HMO
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
FirstCare
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

RETINA CONSULTANTS OF HOUSTON PLLC
10907 Memorial Hermann Dr, Suite 450, Pearland, TX 77584
Call: 713-524-3434

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Biological, Drug
Study Drugs: Adalimumab, Conventional immunosuppression
Study Phase: Phase 3
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
Enrollment Status: Completed
Publish Date: July 10, 2023
Intervention Type: Drug
Study Drugs: Dexamethasone Intravitreal Implant, Intravitreal Methotrexate, Intravitreal Ranibizumab
Study Phase: Phase 3
Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
Enrollment Status: Completed
Publish Date: May 24, 2021
Intervention Type: Drug
Study Phase: Phase 2
Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement
Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement
Enrollment Status: Completed
Publish Date: May 21, 2021
Intervention Type: Drug
Study Drug: Aflibercept Injection
Study Phase: Phase 2
A Randomized, Active-Controlled, Phase II Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation in Subjects With Radiation Retinopathy (RRR Study).
A Randomized, Active-Controlled, Phase II Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation in Subjects With Radiation Retinopathy (RRR Study).
Enrollment Status: Completed
Publish Date: March 25, 2021
Intervention Type: Procedure, Drug
Study Phase: Phase 2
Intravitreal Aflibercept Injection (IAI) for Radiation Retinopathy Trial (ARRT)
Intravitreal Aflibercept Injection (IAI) for Radiation Retinopathy Trial (ARRT)
Enrollment Status: Unknown
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 2
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Enrollment Status: Completed
Publish Date: December 04, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

8 Total Publications

Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy Trial: 24-Week Outcomes of Uveitic Macular Edema Re-treatment.
Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy Trial: 24-Week Outcomes of Uveitic Macular Edema Re-treatment.
Journal: Ophthalmology
Published: August 09, 2024
View All 8 Publications
Similar Doctors
Elite in Age-Related Macular Degeneration (ARMD)
Dr. Charles C. Wykoff
Ophthalmology
Elite in Age-Related Macular Degeneration (ARMD)
Dr. Charles C. Wykoff
Ophthalmology

Retina Consultants Of Houston PLLC

4460 Bissonnet St, Suite 200, 
Bellaire, TX 
 (10.8 miles away)
713-524-3434
Languages Spoken:
English, Spanish, Vietnamese
See accepted insurances
Accepting New Patients

Charles Wykoff is an Ophthalmologist in Bellaire, Texas. Dr. Wykoff is rated as an Elite provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), Vitrectomy, and Cataract Removal. Dr. Wykoff is currently accepting new patients.

Distinguished in Age-Related Macular Degeneration (ARMD)
Dr. Carolyn Chen
Ophthalmology
Distinguished in Age-Related Macular Degeneration (ARMD)
Dr. Carolyn Chen
Ophthalmology

Hea Clinic PA

1699 Research Forest Dr, Suite 150, 
Shenandoah, TX 
 (42.7 miles away)
281-363-2155
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Carolyn Chen is an Ophthalmologist in Shenandoah, Texas. Dr. Chen is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Choroid Plexus Carcinoma. Dr. Chen is currently accepting new patients in some locations.

Distinguished in Age-Related Macular Degeneration (ARMD)
Dr. Christina Y. Weng
Ophthalmology
Distinguished in Age-Related Macular Degeneration (ARMD)
Dr. Christina Y. Weng
Ophthalmology

Baylor College Of Medicine

1977 Butler Blvd, 
Houston, TX 
 (9.7 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Christina Weng is an Ophthalmologist in Houston, Texas. Dr. Weng is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Weng is currently accepting new patients.

VIEW MORE AGE-RELATED MACULAR DEGENERATION (ARMD) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kim's expertise for a condition
ConditionClose
    • Distinguished
    • Neuroretinitis
      Dr. Kim is
      Distinguished
      . Learn about Neuroretinitis.
      See more Neuroretinitis experts
    • Punctate Inner Choroidopathy
      Dr. Kim is
      Distinguished
      . Learn about Punctate Inner Choroidopathy.
      See more Punctate Inner Choroidopathy experts
    • Uveitis
      Dr. Kim is
      Distinguished
      . Learn about Uveitis.
      See more Uveitis experts
    • Advanced
    • Age-Related Macular Degeneration (ARMD)
      Dr. Kim is
      Advanced
      . Learn about Age-Related Macular Degeneration (ARMD).
      See more Age-Related Macular Degeneration (ARMD) experts
    • Diabetic Retinopathy
      Dr. Kim is
      Advanced
      . Learn about Diabetic Retinopathy.
      See more Diabetic Retinopathy experts
    • Eales Disease
      Dr. Kim is
      Advanced
      . Learn about Eales Disease.
      See more Eales Disease experts
    • Endophthalmitis
      Dr. Kim is
      Advanced
      . Learn about Endophthalmitis.
      See more Endophthalmitis experts
    • Hyphema
      Dr. Kim is
      Advanced
      . Learn about Hyphema.
      See more Hyphema experts
    • Late-Onset Retinal Degeneration
      Dr. Kim is
      Advanced
      . Learn about Late-Onset Retinal Degeneration.
      See more Late-Onset Retinal Degeneration experts
    View All 9 Advanced Conditions
    • Experienced
    • Birdshot Chorioretinopathy
      Dr. Kim is
      Experienced
      . Learn about Birdshot Chorioretinopathy.
      See more Birdshot Chorioretinopathy experts
    • Choroid Plexus Carcinoma
      Dr. Kim is
      Experienced
      . Learn about Choroid Plexus Carcinoma.
      See more Choroid Plexus Carcinoma experts
    • Kallikrein Hypertension
      Dr. Kim is
      Experienced
      . Learn about Kallikrein Hypertension.
      See more Kallikrein Hypertension experts
    • Ocular Hypertension (OHT)
      Dr. Kim is
      Experienced
      . Learn about Ocular Hypertension (OHT).
      See more Ocular Hypertension (OHT) experts
    • Scleritis
      Dr. Kim is
      Experienced
      . Learn about Scleritis.
      See more Scleritis experts
    • Vitrectomy
      Dr. Kim is
      Experienced
      . Learn about Vitrectomy.
      See more Vitrectomy experts
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved